S22N (p.Ser22Asn) variant of FBN1 (Fibrillin-1)
S22N (p.Ser22Asn) in FBN1 (Fibrillin-1) is a missense change. Clinical records from UniProt describe it as variant assessed as somatic; moderate impact.
S22N (p.Ser22Asn) variant details
- p.Ser22Asn
- NCI-TCGA TCGA novel
- Variant assessed as somatic; moderate impact.
- Missense
- UniProt: Variant assessed as somatic; moderate impact.